We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound Guiding

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2010 by Sun Yat-sen University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01256138
First Posted: December 8, 2010
Last Update Posted: December 8, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sun Yat-sen University
  Purpose
Allogene MSCs transplantation will be performed in patients with chronic liver diseases through portal vein by ultrasound guiding and therapeutic effects including short-term effects and long-term follow-up will be compared and investigated.

Condition
Allogene Transplantation Chronic Liver Diseases Patients Through Portal Vein by Ultrasound Guiding

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Sun Yat-sen University:

Primary Outcome Measures:
  • Short-term therapeutic effects at 1-8 weeks after Allogene MSCs transplantation [ Time Frame: 1-8 weeks ]

Estimated Enrollment: 60
Study Start Date: October 2010
Groups/Cohorts
transplantation
control

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with chronic liver diseases including: viral hepatitis, alcoholic liver disease, autoimmune liver disease and so on.
Criteria

Inclusion Criteria:

  1. chronic liver diseases including: viral hepatitis, alcoholic liver disease, autoimmune liver disease.
  2. age: 15-65 years old.

Exclusion Criteria:

  1. pregnant women and women in lactation.
  2. other systems and organs disfunction
  3. space-occupying lesion were found in liver.
  4. concurrent infection with HIV and other immunodeficiency diseases.
  5. DIC and active bleeding were confirmed.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01256138


Locations
China, Guangdong
Department of Infectious Diseases, 3rd Affiliated Hospital of Sun Yat-sen University Recruiting
Guangzhou, Guangdong, China, 510630
Contact: Liang Peng, Dr.    +86-013533978874    pzp33@hotmail.com   
Contact: Jing Liu, Master.    +86-013556051920    diudiu1203@163.com   
Sponsors and Collaborators
Sun Yat-sen University
  More Information

Responsible Party: Zhi-liang Gao, Department of Infectious Diseases, 3rd Affiliated Hospital of Sun Yat-sen University
ClinicalTrials.gov Identifier: NCT01256138     History of Changes
Other Study ID Numbers: SunYat-sen U 11-5-2
First Submitted: December 7, 2010
First Posted: December 8, 2010
Last Update Posted: December 8, 2010
Last Verified: October 2010

Keywords provided by Sun Yat-sen University:
Allogene MSCs
transplantation
chronic liver diseases
portal vein

Additional relevant MeSH terms:
Liver Diseases
Digestive System Diseases